Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease ; volume:12 ; number:1 ; day:17 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.11.2022), 1-12, 12.2022
- Creator
-
Saito, Kosuke
Gemma, Akihiko
Tatsumi, Koichiro
Hattori, Noboru
Ushiki, Atsuhito
Tsushima, Kenji
Saito, Yoshinobu
Abe, Mitsuhiro
Horimasu, Yasushi
Kashiwada, Takeru
Mori, Kazuhiko
Sato, Motonobu
Nishiya, Takayoshi
Takamatsu, Kazuhiko
Sun, Yuchen
Arakawa, Noriaki
Izumi, Takashi
Ohno, Yasuo
Saito, Yoshiro
Hanaoka, Masayuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-24406-z
- URN
-
urn:nbn:de:101:1-2023013021132649645085
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Saito, Kosuke
- Gemma, Akihiko
- Tatsumi, Koichiro
- Hattori, Noboru
- Ushiki, Atsuhito
- Tsushima, Kenji
- Saito, Yoshinobu
- Abe, Mitsuhiro
- Horimasu, Yasushi
- Kashiwada, Takeru
- Mori, Kazuhiko
- Sato, Motonobu
- Nishiya, Takayoshi
- Takamatsu, Kazuhiko
- Sun, Yuchen
- Arakawa, Noriaki
- Izumi, Takashi
- Ohno, Yasuo
- Saito, Yoshiro
- Hanaoka, Masayuki
- SpringerLink (Online service)
Other Objects (12)
Drug-induced uveitis
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Drug-induced notched T waves
Emerging mechanisms of drug-induced phospholipidosis
Transcriptomic signature for drug-induced steatosis
Drug-induced small-bowel mucosal atrophy
Drug-induced uveitis
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Drug-induced notched T waves
Emerging mechanisms of drug-induced phospholipidosis
Transcriptomic signature for drug-induced steatosis
Drug-induced small-bowel mucosal atrophy
Drug-induced uveitis
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease
Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Drug-induced notched T waves
Emerging mechanisms of drug-induced phospholipidosis
Transcriptomic signature for drug-induced steatosis